When the coronavirus vaccine is injected, the mRNA contains “instructions” for building the spike protein that has been identified on the surface of the SARS-CoV2 virus. The cell’s reverse transcriptase enzymes are called into action, leading to the mass production of the spike (S) protein, the protein thought to play a vital role in its infectivity.
The 2019 study by Liu, Li et al, “Anti-spike IgG antibody causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection” is worthy of your time to read and study.
What the researchers discovered was startling.
Sixteen macaque monkeys were given two injections; half of the animals received a modified vaccinia virus with an inserted spike protein (ADS-MVA) or a control vaccine made with a modified vaccinia virus without the spike protein antigen (ADC-MVA). Three healthy, non-vaccinated monkeys were included as additional controls.
The animals were sacrificed between weeks 9 and 21, after receiving the second injection; the vaccine containing the spike protein induced very high antibody responses to the spike protein (anti-S-IgG). Although the antibodies had reduced the viral load in the upper respiratory tract, they caused a serious, antibody-enhanced injury in the lungs. In fact, there was a direct and positive correlation between the level of antibody in serum and the degree of lung injury. The tissues had evidence of diffuse alveolar damage (DAD), with various degrees of exudate (pus-like fluid) and hemorrhage (bleeding).
Even more, the lungs were large filled with large quantities of macrophages (pus) that had been weakened and inactivated.
This is the process of how antibody derived enhancement, or ADE, works. It’s like having an “on button” on a replicator but no “off button.” As the mRNA replicates, more and more non-neutralizing antibody is produced, leading to accelerated autoimmune diseases, primarily affecting the lungs, liver and kidneys. ADE may even plan a role in the development of fulminant ARDS (Acute Respiratory Distress Syndrome) after patients have recovered from COVID.Coronavirus Pt. 6: The COVID Vaccines – part 2 – UPDATED – Vaxxter